Abstract
Breast cancer remains a leading cause of cancer-related morbidity and mortality worldwide, with oxidative stress recognized as a critical factor contributing to tumor initiation, progression, and therapeutic resistance. Catechins and their derivatives, a class of plant-derived flavan-3-ols, have gained increasing attention due to their potent radical-scavenging properties and their role in regulating cellular redox homeostasis that is involved in cancer. This systematic literature review aims to evaluate experimental evidence published between 2015 and 2025 regarding the radical-scavenging activity of catechins in breast cancer models and their associated biological effects. Literature searches were conducted using PubMed, Scopus, and ScienceDirect databases following PRISMA-guided screening procedures. A total of 7 eligible studies were included after systematic filtering and eligibility assessment. The findings demonstrate that catechins, particularly epigallocatechin-3-gallate (EGCG) and its derivatives, are capable of directly neutralizing reactive oxygen species through hydrogen-donating mechanisms and electron transfer processes. In addition, these compounds modulate endogenous antioxidant systems and regulate redox-sensitive signaling pathways, including those associated with apoptosis, proliferation, and inflammation. These effects are further linked to the modulation of broader cellular processes such as autophagy and epigenetic regulation, contributing to the complex mechanistic actions of catechins in breast cancer models. Experimental evidence consistently indicates enhanced apoptotic activity, suppression of proliferative signaling, inhibition of inflammatory mediators, and a reduction in metastatic potential in breast cancer cells. Under specific cellular conditions, catechins may also exhibit selective pro-oxidant effects that increase cancer cell susceptibility to conventional treatments. These findings highlight the redox-modulating behavior of catechins in preclinical breast cancer models and support their potential as bioactive compounds. However, their clinical relevance remains to be established through well-designed clinical studies, particularly with respect to efficacy, safety, and pharmacokinetic performance.